NARA Discovery
Article Details
← Back to Search Results
Journal Article

Elevated IL-22 in psoriasis plays an anti-apoptotic role in keratinocytes through mediating Bcl-xL/Bax

Bo Wang; Dan Han; Fei Li; Weikun Hou; Lijuan Wang; Liesu Meng; Kuanhou Mou; Shemin Lu; Wenhua Zhu; Yan Zhou
Apoptosis · Vol. 25, Issue 9-10 · pp. 663-673 · 2020

Abstract

IL-22 is known to mediate inflammation in psoriasis, while IL-22 binding protein (IL-22BP) binds IL-22 to suppress IL-22 signaling. However, the function of IL-22 in regulating apoptosis in psoriasis remains poorly understood. In this study, we found that IL-22/IL-22R1 in lesional skin and IL-22 in serum from psoriatic patients were highly upregulated compared with healthy controls, while IL-22BP was not changed. Correlations between IL-22/IL-22R1 levels and the thickness of psoriatic lesions suggested that IL-22 might positively regulate abnormal hyperplasia in psoriasis. Apoptotic keratinocytes were increased only in stratum corneum, but not in spinous and basal layers of psoriasis. Moreover, IL-22 promoted cell viability in human epidermal keratinocytes (HEKs). The apoptosis induced by TNF-α and IFN-γ was inhibited in HEKs treated with IL-22, since that IL-22 upregulated Bcl-xL and downregulated Bax production in HEKs in the presence of TNF-α and IFN-γ. In addition, IL-22BP could counteract the anti-apoptotic effect of IL-22. Our finding demonstrates that IL-22 might play an anti-apoptosis role on keratinocytes to balance cell proliferation and apoptosis in psoriatic epidermis.

Bibliographic Information

JournalApoptosis
PublisherSpringer
Publication Date2020-10-01
Publication Year2020
Volume25
Issue9-10
Pages663-673
Document TypeJournal Article
Print ISSN1360-8185
eISSN1573-675X
DOI10.1007/s10495-020-01623-3

Access Information

NARA Access Coverage1996-01-01~Current
Journal Homepagehttps://www.springer.com/journal/10495
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.